HRTX
Price
$2.20
Change
+$0.05 (+2.33%)
Updated
Jul 3 closing price
Capitalization
335.64M
37 days until earnings call
IDRSF
Price
$2.40
Change
+$0.15 (+6.67%)
Updated
Jun 27 closing price
Capitalization
592.71M
Interact to see
Advertisement

HRTX vs IDRSF

Header iconHRTX vs IDRSF Comparison
Open Charts HRTX vs IDRSFBanner chart's image
Heron Therapeutics
Price$2.20
Change+$0.05 (+2.33%)
Volume$823.59K
Capitalization335.64M
Idorsia AG
Price$2.40
Change+$0.15 (+6.67%)
Volume$457
Capitalization592.71M
HRTX vs IDRSF Comparison Chart in %
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. IDRSF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and IDRSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (HRTX: $2.20 vs. IDRSF: $2.40)
Brand notoriety: HRTX and IDRSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 47% vs. IDRSF: 49%
Market capitalization -- HRTX: $335.64M vs. IDRSF: $592.71M
HRTX [@Biotechnology] is valued at $335.64M. IDRSF’s [@Biotechnology] market capitalization is $592.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileIDRSF’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • IDRSF’s FA Score: 0 green, 5 red.
According to our system of comparison, HRTX is a better buy in the long-term than IDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 5 TA indicator(s) are bullish while IDRSF’s TA Score has 2 bullish TA indicator(s).

  • HRTX’s TA Score: 5 bullish, 3 bearish.
  • IDRSF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than IDRSF.

Price Growth

HRTX (@Biotechnology) experienced а +1.85% price change this week, while IDRSF (@Biotechnology) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

HRTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDRSF($593M) has a higher market cap than HRTX($336M). IDRSF YTD gains are higher at: 182.353 vs. HRTX (43.791). HRTX has higher annual earnings (EBITDA): 2.76M vs. IDRSF (-189.01M). IDRSF has more cash in the bank: 64.8M vs. HRTX (50.7M). HRTX has less debt than IDRSF: HRTX (177M) vs IDRSF (1.25B). IDRSF has higher revenues than HRTX: IDRSF (161M) vs HRTX (149M).
HRTXIDRSFHRTX / IDRSF
Capitalization336M593M57%
EBITDA2.76M-189.01M-1%
Gain YTD43.791182.35324%
P/E RatioN/A4.54-
Revenue149M161M93%
Total Cash50.7M64.8M78%
Total Debt177M1.25B14%
FUNDAMENTALS RATINGS
HRTX vs IDRSF: Fundamental Ratings
HRTX
IDRSF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5035
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (66) in the Biotechnology industry is in the same range as IDRSF (81) in the null industry. This means that HRTX’s stock grew similarly to IDRSF’s over the last 12 months.

HRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IDRSF (100) in the null industry. This means that HRTX’s stock grew similarly to IDRSF’s over the last 12 months.

HRTX's SMR Rating (100) in the Biotechnology industry is in the same range as IDRSF (100) in the null industry. This means that HRTX’s stock grew similarly to IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (35) in the null industry is in the same range as HRTX (50) in the Biotechnology industry. This means that IDRSF’s stock grew similarly to HRTX’s over the last 12 months.

IDRSF's P/E Growth Rating (98) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that IDRSF’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXIDRSF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
70%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
51%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OERLF4.60N/A
N/A
OC Oerlikon Corp.
SKSUY85.79N/A
N/A
Sekisui Chemical Co.
RVTI0.02N/A
N/A
Rival Technologies, Inc.
ITOCF51.05-2.29
-4.30%
Itochu Corp.
WAMFF0.48-0.12
-20.00%
Alaska Silver Corp

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with ABOS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
+2.33%
ABOS - HRTX
39%
Loosely correlated
+2.65%
ACAD - HRTX
39%
Loosely correlated
-1.37%
ARDX - HRTX
38%
Loosely correlated
+1.91%
RNAC - HRTX
36%
Loosely correlated
-1.41%
ABSI - HRTX
36%
Loosely correlated
+2.97%
More

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and CADL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
N/A
CADL - IDRSF
25%
Poorly correlated
+2.20%
NDTP - IDRSF
22%
Poorly correlated
N/A
ANNX - IDRSF
22%
Poorly correlated
+2.85%
HRTX - IDRSF
21%
Poorly correlated
+2.33%
LGVN - IDRSF
21%
Poorly correlated
+0.77%
More